1-32864696-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_153756.3(FNDC5):c.601G>C(p.Glu201Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,614,066 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153756.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FNDC5 | NM_153756.3 | c.601G>C | p.Glu201Gln | missense_variant | Exon 5 of 6 | ENST00000373471.9 | NP_715637.2 | |
FNDC5 | NM_001171941.3 | c.376G>C | p.Glu126Gln | missense_variant | Exon 5 of 5 | NP_001165412.1 | ||
FNDC5 | NM_001171940.2 | c.531+70G>C | intron_variant | Intron 5 of 5 | NP_001165411.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FNDC5 | ENST00000373471.9 | c.601G>C | p.Glu201Gln | missense_variant | Exon 5 of 6 | 2 | NM_153756.3 | ENSP00000362570.5 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251480Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135920
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461862Hom.: 0 Cov.: 68 AF XY: 0.0000289 AC XY: 21AN XY: 727228
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.376G>C (p.E126Q) alteration is located in exon 5 (coding exon 3) of the FNDC5 gene. This alteration results from a G to C substitution at nucleotide position 376, causing the glutamic acid (E) at amino acid position 126 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at